US Attorney: Pharmacies robbed… stolen drugs sold on the street… DUH !!!


Federal charges filed in pharmacy robbery cases

INDIANAPOLIS (WISH) — Prosecutors charged nine adults and several juveniles in federal court in a string of pharmacy robberies.

There were 24 robberies total, dating back to October 2014. The US Attorney’s office traced them back to a gang known as “The Mob.”

They said the gang’s actions were funneling drugs into the streets. An operation they say is now over.

“My message now is clear: the days of the mob ruining the neighborhood is over,” said Josh Minkler, the US Attorney for Southern Indiana.

The individuals are now charged with racketeering, robbery, drug distribution, and firearms charges.

Minkler says they robbed pharmacies and then sold the stolen drugs on the streets.

They would even recruit juveniles, some as young as 12-years-old, and then intimidate them using social media.

One of the posts came from Facebook. Minkler says it read: “He got to die, if he testify. We do not work with the FBI.”

This investigation began in 2015, after someone shot and killed a 19-year-old in connection to a pharmacy robbery.

This is the same year Indiana ranked #1 for pharmacy robberies.

“Indianapolis never wants to be number 1 in those categories,” said Bryan Roach, the IMPD chief.

Authorities say the actions of the mob helped to contribute to the state’s opioid addiction problems.

“Criminal drug trafficking organizations exploit the addicted, poison our streets, and leave a trail of violence throughout our communities,” said Greg Westfall of the Drug Enforcement Agency. The lawyers for wrongful death cases from The Law Offices of Thomas J. Lavin are usually there to help citizens deal with the legalities of a case.

One fugitive, Duwan Byers remains on the loose.

They say their work will continue even after he is captured.

“Community, we heard you. We saw a problem, we addressed the problem. We’re not done yet,” said Trevor Velinor of the Bureau of Alcohol, Tobacco, Firearms and Explosives.

Since the early – mid 70’s it has been a FEDERAL CRIME – the same as robbing a bank – when a pharmacy is robbed and controlled substances are involved.  This is the first incident – that I have seen – where that 40 y/o Federal Law is being used against those robbing a pharmacy.  Did it take 24 pharmacies being robbed to get the FBI to act ?

Where is the Board of Pharmacy, FBI, DEA taking no action against these pharmacies – mostly chains – that have been reluctant to make their Rx depts more physically robbery resistant.   What are they waiting on… Rx dept staff or customers to get hurt/killed ?  More robberies that are allowing more drugs on the streets ?

FDA: soliciting public input… BUT.. WILL THEY LISTEN ?

FDA Commissioner Asks Staff for ‘More Forceful Steps’ to Stem the Opioid Crisis

blogs.fda.gov/fdavoice/index.php/2017/05/fda-commissioner-asks-staff-for-more-forceful-steps-to-stem-the-opioid-crisis/

By: Scott Gottlieb, M.D.

As Commissioner, my highest initial priority is to take immediate steps to reduce the scope of the epidemic of opioid addiction. I believe the Food and Drug Administration continues to have an important role to play in addressing this crisis, particularly when it comes to reducing the number of new cases of addiction.

Dr. Scott GottliebToday, I sent an email to all of my colleagues at FDA, sharing with them the first steps I plan to take to better achieve this public health goal. With this, my first post to the FDA Voice blog, I also wanted to share my plans with you.

I believe it is within the scope of FDA’s regulatory tools – and our societal obligations – to take whatever steps we can, under our existing legal authorities, to ensure that exposure to opioids is occurring under only appropriate clinical circumstances, and for appropriate patients.

Patients must be prescribed opioids only for durations of treatment that closely match their clinical circumstances and that don’t expose them unnecessarily to prolonged use, which increases the risk of opioid addiction. Moreover, as FDA does in other contexts in our regulatory portfolio, we need to consider the broader public health implications of opioid use. We need to consider both the individual and the societal consequences.

While there has been a lot of good work done by FDA to date, and many people are working hard on this problem, I have asked my FDA colleagues to see what additional, more forceful steps we might take.

As a first step, I am establishing an Opioid Policy Steering Committee that will bring together some of the agency’s most senior career leaders to explore and develop additional tools or strategies FDA can use to confront this crisis.

I have asked the Steering Committee to consider three important questions. However, the Committee will have a broad mandate to consider whatever additional questions FDA should be seeking to answer. The Committee will solicit input, and engage the public. I want the Committee to go in whatever direction the scientific and public health considerations leads, as FDA works to further its mandate to confront the crisis of opioid addiction.

The initial questions I have tasked the Steering Committee to answer are:

  1. Are there circumstances under which FDA should require some form of mandatory education for health care professionals, to make certain that prescribing doctors are properly informed about appropriate prescribing recommendations, understand how to identify the risk of abuse in individual patients, and know how to get addicted patients into treatment?
  2. Should FDA take additional steps, under our risk management authorities, to make sure that the number of opioid doses that an individual patient can be prescribed is more closely tailored to the medical indication? For example, only a few situations require a 30-day supply. In those cases, we want to make sure patients have what they need. But there are plenty of situations where the best prescription is a two- or three-day course of treatment. So, are there things FDA can do to make sure that the dispensing of opioids more consistently reflects the clinical circumstances? This might require FDA to work more closely with provider groups to develop standards for prescribing opioids in different clinical settings.
  3. Is FDA using the proper policy framework to adequately consider the risk of abuse and misuse as part of the drug review process for the approval of these medicines? Are we doing enough when we evaluate new opioid drugs for market authorization, and do we need additional policies in this area?

These are just some of the questions I will be asking this new Steering Committee to consider right away, given the scope of the emergency we face. In the coming days, I’ll continue to work closely with the senior leadership of FDA. I want to know what other important ideas my colleagues at FDA may have, so that we can lean even further into this problem, using our full authorities to work toward reducing the scope of this epidemic.

Despite the efforts of FDA and many other public health agencies, the scope of the epidemic continues to grow, and the human and economic costs are staggering. According to data from CDC and SAMHSA, nearly 2 million Americans abused or were dependent on prescription opioids in 2014, and more than 1,000 people are treated in emergency departments each day due to misusing prescription opioids.

Opioid overdose deaths involving prescription opioids have quadrupled since 1999. In 2015, opioids were involved in the deaths of 33,091 people in the United States. Most of these deaths – more than 22,000 (about 62 people per day) – involved prescription opioids.

We know that the majority of people who eventually become addicted to opioids are exposed first to prescription opioids. One recent study found that in a sample of heroin users in treatment for opioid addiction, 75% of those who began abusing opioids in the 2000s started with prescription opioid products.

This March, a study published in CDC’s Morbidity and Mortality Weekly Report, found that opioid-naïve patients who fill a prescription for a one-day supply of opioids face a 6% risk of continuing their use of opioids for more than one year. This study also found that the longer a person’s first exposure to opioids, the greater the risk that he or she will continue using opioids after one, or even three years. For example, when a person’s first exposure to opioids increases from one day to 30 days, that person’s likelihood of continuing to use opioids after one year increases from 6% to about 35%.

Working together, we need to do all we can to get ahead of this crisis. That’s why we’ll also be soliciting public input, through various forums, on what additional steps FDA should consider. I look forward to working closely with my FDA colleagues as we quickly move forward, capitalizing on good work that has already been done, and expanding those efforts in novel directions. I will keep you updated on our work as we continue to confront this epidemic.

Scott Gottlieb, M.D., is Commissioner of the U.S. Food and Drug Administration

Follow Commissioner Gottlieb on Twitter @SGottliebFDA

Are more mistakes happening at pharmacies?


Are more mistakes happening at pharmacies?

http://www.fox9.com/news/256247742-story

(KMSP) – A Fox 9 Investigation looks at mistakes at Minnesota pharmacies and how complaints are on the rise.

In one instance a customer was given the wrong prescription, and a blood clot formed and a paralyzing stroked occurred. The damage was permanent.

A confidentiality agreement prevents the person from talking about it publicly.

The Executive Director of the MN Board of Pharmacy, Cody Wiberg, said they don’t know with certainty how often errors occur.

Drug stores are filling more prescriptions than ever, at some locations as many as 800 a day, and it’s not uncommon for some pharmacists to work 14 hours straight.

Volume often makes up for lower reimbursements from insurance.

CHAOS IN THE PHARMACY

Pharmacist Lyla Aaland is able to speak freely because she is now retired.

The Fox 9 Investigators contacted her after reviewing a file obtained from the pharmacy board.

She was among dozens of pharmacists who wrote the group to share concerns about working conditions.

“Chaos in the pharmacy, busy, phone calls, drive thru, too many interruptions, that’s what it is,” she said.

The records checked by Fox 9 offer rare insight into what’s going on behind the drug store counter.

“14 hour days with no breaks are extremely exhausting and lead to errors,” wrote one pharmacist in the reports.

Another wrote “there is no question that fatigue becomes a problem.”

Insiders said that as it all adds up, it becomes more likely that mistakes will happen.

MORE COMPLAINTS

“We’re getting more complaints than we’ve ever received,” Wiberg said.

When he joined the pharmacy board more than a decade ago, consumers filed maybe 100 complaints a year.

Now he said the number has nearly tripled.

“We also know that for every complaint that we get, there are many more errors that are never reported to us,” he said.
 
On occasion, the state has fined a drug store for giving a medication to the wrong patient. But regulators really have no idea when errors happen, unless someone registers a formal complaint with the pharmacy board.

That’s because drug stores are not required to report that data.

They are, however, supposed to keep an internal log of mistakes. An industry trade group said that approach “emphasizes correcting and preventing future errors.”

Aaland said while she always reported any mistakes, some of her colleagues did not, primarily because they were so busy.

SILENCE AFTER A SETTLEMENT

When mistakes cause serious injury or even death, the cases are often settled out of court with a clause that no one can talk about it.

Personal Injury Attorney Jeff Sieben had a client who was mistakenly given pain killers instead of diabetes medicine.  It impaired his driving, causing a crash and injury.

“They don’t want the general public to know of a problem,” he said.

He added the case involved a well-known drug chain, but couldn’t disclose the name due to the settlement terms.   

CONSULTS ARE KEY

Druggists are supposed to discuss every new prescription with the customer.

It’s a way to prevent errors by confirming the medication in the bag is appropriate.

“[Consults] supposed to [happen] and people will say they are doing it. But it’s the one thing that I think gets put by the wayside,” said Aaland.

According to state regulators, lack of consults is one of the main reasons why pharmacists might be disciplined; it’s considered such a crucial step in the safety process.

Fox 9 asked the National Association of Chain Drug Stores for an interview.

They declined but in a statement said “Patient safety is a pharmacy’s top priority…Pharmacies constantly pursue opportunities to improve safety..”

PHARMACISTS’ HOURS TO BE LIMITED

Under a new rule by the Pharmacy Board starting July 1, Minnesota will no longer allow pharmacists to work more than 12 hours in a row, and they’ll be required to get mandatory breaks.

“This is an attempt to relieve that stress that we acknowledge is out there so pharmacists are less likely to make errors,” said Wiberg
     
Customers have a safety role in all of this too. When the pharmacist asks questions, they should take the time to answer. Studies show that it’s during those discussions that mistakes come to light.

Full statement from the National Association of Chain Drug Stores:

Patient safety is a pharmacy’s top priority. Recognizing that human error is a possibility in any profession, pharmacies constantly pursue opportunities to improve safety. One example is updating and enhancing quality assurance and training programs for pharmacy personnel. Another example is using workflow and technology innovations to help reduce the chances of human error. Scanning technology is used in some instances to verify that the medication that has been prescribed matches the medication actually being dispensed. Also, the use of electronic prescribing is on the rise. E-prescribing can reduce the risk of errors from prescribers’ handwriting and from incorrectly entering prescription information.  

In addition to patient-safety-focused processes and technology, community pharmacies have provided feedback to the Minnesota Board of Pharmacy on the pharmacist work rule surrounding breaks. As responsible and highly educated professionals, pharmacists’ judgments are more effective than rigid rules when it comes to decisions about breaks. The work rule taking effect July 1 reflects input provided by community pharmacies to the Minnesota Board of Pharmacy. The Board arrived at a reasonable approach in its final work rule, and we appreciated the opportunity to provide context throughout their process. In the end, everyone agrees that the best policies should be consistent with a pharmacist’s ability to meet the needs of patients and put safety first.

Also, the pharmacy community supports legislation that fosters quality assurance programs and patient safety for all healthcare providers, including pharmacies. Further, we support voluntary reporting of medical and prescription errors in a non-punitive forum, with a focus on strategies and education to help identify an error’s root cause. This approach, common among healthcare professions, emphasizes correcting and preventing future errors.

What everyone should know about the LIES THEY TELL ABOUT OPIATES

What Everyone Should Know About Opioids

http://www.refinery29.com/2017/05/154770/what-are-opiate-drugs

In the past 15 years or so, deaths related to heroin and prescription opioids have quadrupled in the U.S., according to the CDC. And opioid addiction is becoming an increasingly widespread issue, especially among young women. So how did we get here?
“The first thing you have to understand [is that] our opioid crisis is not a drug abuse problem — it’s not a problem of people taking dangerous drugs because it feels good and they’re accidentally harming themselves… The opioid crisis is an epidemic of opioid addiction,” says Andrew Kolodny, MD, co-director of opioid policy research collaboration at Brandeis University and a medical advisor for the recently released HBO documentary Warning: This Drug May Kill You.
However, when we talk about the opioid crisis as if it’s a drug abuse or misuse problem, Dr. Kolodny says, “that suggests that there are a lot of people behaving badly and [our issue is figuring out] how we stop them from behaving badly — and that isn’t the case.”
Ahead, we talked to Dr. Kolodny about what these drugs really are, why we’re facing this crisis now, and how we can help those most severely affected get the treatment they need.
Let’s start with the basics: What are opioid drugs?
“Opioids are drugs that come from opium. Some of the more commonly prescribed opioids are drugs like hydrocodone and oxycodone, which literally come from opium — you need opium to make them. Hydrocodone is in Vicodin and oxycodone is in Percocet and Oxycontin.
“They are both what we would term ‘semi-synthetic’ opioids because you start with something natural and you treat it chemically to create a more potent version of opium. Heroin is also a semi-synthetic opioid.
“Many people don’t realize — including many of the doctors who prescribe opioids — that the effects of drugs like oxycodone and hydrocodone are indistinguishable from the effects produced by drugs like heroin. So if you’ve ever been curious about what heroin feels like, if you’ve had a Vicodin, that’s basically the same thing.”

When taken on a daily basis long-term, opioids are really lousy drugs.

We hear so much about misuse of opioids — so what are opioid drugs supposed to be used for?
“These are very important medicines for easing suffering at the end of life. They’re also very useful when used on a short-term basis for severe acute pain, after major surgery or a serious accident, for example.
“Unfortunately, the bulk of the prescribing of opioids in the U.S. is not for end-of-life care or a couple of days after surgery — it’s for common conditions where opioids may be more likely to harm the patient than help them. In fact, we have about 10-12 million Americans who are on opioids for chronic pain. They’re taking them every day. They take a drug like Oxycontin…every day, morning and night, for months or years. We have so many people on daily opioids that drug companies that can now make money off of drugs to treat the side effects of opioids, such as constipation.
“When taken on a daily basis long-term, opioids are really lousy drugs. One reason is that they’re addictive … But also, opioids have some unique characteristics: You very quickly develop a tolerance to the pain-relieving effects, meaning you’ll need higher and higher doses in order to continue getting to get pain relief. And the other effect is what we call ‘physiological dependence,’ which means that if you try to stop taking the drug after taking it on a regular basis, you feel very sick — not just a flu-like illness, but you can also feel very severe anxiety and agonizing pain as a symptom of opioid withdrawal.
“So the other problem with taking them long-term [besides addiction] is that evidence tells us they don’t work — they can become ineffective and make pain worse.”
These drugs have been around for decades — why are we seeing the epidemic now?
“Beginning around 20 years ago, the medical community decided to prescribe [opioids] much more aggressively. The prescribing of opioids quadrupled from around 1999 to 2012. As prescribing starts to go up rapidly, it leads to this parallel increase in addiction and overdose deaths. In other words, the epidemic has been caused by doctors overprescribing opioids, and they really overexposed the U.S. population to prescription opioids.
“What led to the change in culture of prescribing? Starting in the late ’90s with the release of oxycontin by Purdue Pharma, that launched a multifaceted campaign designed to increase opioid prescribing. When they were putting Oxycontin on the market, which is extended-release oxycodone, [drugs like that were mostly] used in palliative care settings.
“Purdue wouldn’t have been able to have much financial success had it only been used in palliative care — patients at the end of their lives with cancer pain is not a common condition, and the patients won’t be under medicine for very long. They needed to see it prescribed for common, especially chronic problems.
“So the campaign they launched was focused on getting the medical community more comfortable with opioids as a class of drug. Purdue would ultimately get into trouble in 2007 for some of the specific ways they marketed Oxycontin as less addictive [than other opioids]. But what they never really got in trouble for (which was much more damaging) was to mislead the medical community about the safety and effectiveness of using opioids on a long-term basis.
“As part of the campaign, doctors started to hear that they were allowing patients to suffer needlessly because we were under-prescribing opioids. We would start hearing that the risk of addiction had been overblown, that legitimate pain patients very rarely get addicted. A statistic that was used was that ‘much less than 1%’ of our patients will get addicted. We started hearing that, for just about any complaint of pain, opioids are ‘the safest and most effective option.’
“We didn’t just hear it from the drug companies — doctors would have been smart enough to be skeptical of marketing from a drug company — but the marketing was really, in many ways, disguised as education. The medical community began hearing from pain specialists eminent in the field all of these messages, we start hearing it from professional societies, state medical boards… From just about every direction we began hearing that, ‘If you’re an enlightened, caring doctor, you’ll be different form those stingy, puritanical doctors of the past that let people suffer.’
“As we responded to this brilliant campaign and as opioid prescribing took off, it led to a public health catastrophe.”

As we responded to this brilliant campaign and as opioid prescribing took off, it led to a public health catastrophe.

What is the ideal treatment plan for opioid addiction?
“Most people with opioid addiction don’t do well with abstinence-based approaches, meaning going for detox or going to a rehab for 30 days and then coming home. That doesn’t work for many people and, in fact, when you come back from detox, rehab, or jail and your tolerance has gone back to normal, people are at a very high risk for an overdose death.
“There’s also a drug called Vivitrol, which is a monthly injection of naltrexone (an opioid blocker). Even though that’s a medicine, that’s really more of an abstinence-based approach.
“So the first-line treatment for opioid addiction is a medicine called burpenorphine (or Suboxone). In some cases methadone maintenance is a good option, especially for patients with a more severe addiction who need the structure of visiting a methadone maintenance clinic on a daily basis.
“Unfortunately there’s not adequate access to buprenorphine. There are many restrictions and rules that limit the ability of doctors to treat people with this medicine, which is pretty crazy because buprenorphine is much safer than drugs like Oxycontin. For the more dangerous opioids that are causing addiction and people are overdosing on, there are very few restrictions. Yet for the medicine used to treat opioid addiction, we have too many restrictions.”
Why is the use of buprenorphine sometimes considered “controversial” ?
“Among experts, there is no controversy about using buprenorphine. But there is a strong stigma and bias against these treatments, including very concerning statements by HHS Secretary Tom Price a few days ago. But there are many people who are making the mistake of thinking [treatment with buprenorphine] is substituting one opioid drug for another.
“I’ve treated patients with opioid addiction by prescribing them buprenorphine for many years. I didn’t have too much success getting them off buprenorphine — it’s very hard to come off without relapsing — but while my patients are on it, I’ve watched them lead very productive lives. They get married, have babies, graduate college, hold good jobs — you would never know looking at them that they were on a drug. They would tell you they felt perfectly normal.
“It’s certainly not a cure, and it would be nice if we had other options. It’s certainly always better if someone can manage a chronic illness without taking a medicine… but it’s similar to diabetes. For type 2 diabetes, if someone can really control their diet and lose weight and exercise regularly, they can get off their insulin and just be on oral hypoglycemics. And if they do a really good job, they can even get off the oral medicine. That’s definitely better than being on insulin or pills, which have side effects.
“But a lot of people can’t do it. And if you insist on it — if we told people, ‘You can only have your insulin for six months and then you have to be better,’ we’d be in a really bad place. We’d see a lot of people going blind or losing limbs from untreated diabetes. That’s kind of where we are with opioid addiction, because not enough people are accessing the treatments that are effective.”

What PharmD’s say about their education

What PharmD’s say about their education

being prepared for a “job” that doesn’t exist… and NOT PREPARED for the “job” that does exist ?


I begged my pharmacy school (a relatively new one) to spend some actual practical time on drug interactions, high doses, overdoses, and basic toxicology. They just weren’t interested! One professor said that they were considering an interaction elective!!!! An effing ELECTIVE for an important part of our job! RIDICULOUS!

Modern pharmacy schools are obsessed with turning us into mini-doctors instead of the “drug experts” that they kept claiming we would be upon graduation! Myself and a number of students were quite vocal about our rudimentary instruction in drugs, while we spent hours upon hours learning to diagnose diseases when no one was gonna ask us to so in the real world!

Couple that BS with working at break neck speed or being told that they’ll replace you with someone faster…….it’s a recipe for disaster!


we spent so much time basically triaging imaginary patients and developing detailed care plans it was ridiculous. But when I’d say, “are we gonna cover proper dosing, or adverse drug events, etc,” they say, “well that stuff is really learned in practice later on.” WTF?


 

Addiction started with Rx opiates… OBTAINED ILLEGALLY !!!

Per DEA… most opiate addictions start with prescription opiates… just don’t mention the details of how they were obtained ?

Confessions of a DEA Agent: When Everything’s Illegal Nothing’s Illegal

CRPS/RSD Awareness Walk

More healthcare needed than Maine can afford ?

Eastern Maine Medical Center staff walk down a hallway in the hospital in Bangor. Cooperation is essential to addressing health care challenges in Maine

https://bangordailynews.com/2017/05/21/opinion/contributors/cooperation-is-essential-to-addressing-health-care-challenges-in-maine/

The health care challenges that we as Americans face are significant. An aging population, high prevalence of chronic diseases, stretched public and private budgets, and a lack of health insurance for nearly one in nine of our citizens are realities we need to recognize and address.

Here in Maine, these challenges are even tougher because our population is the oldest and most rural in the country. Older adults simply require more care to stay healthy. And while we as Mainers love our state’s natural beauty and independent way of life, it’s more costly to serve a population spread out across a very large geography.

Many of Gov. Paul LePage’s budget decisions have further added to the challenges of providing high-quality care in Maine. During the past four years, hospitals have dealt with the negative impact of Medicaid (also known as MaineCare) reimbursement cuts, increased hospital taxes and narrowing MaineCare eligibility, which leads to more uninsured and needed charity care. These are annual cuts of $55 million that were imposed when Maine’s Medicaid program had a significant deficit in 2013. Hospital payments have been reduced by more than $200 million since 2013 because of these initiatives. Additionally, the hospital tax was increased. The Eastern Maine Health Systems total hospital tax resulted in an annual net negative impact of $5 million.

As a result, since 2012, an average of 18 Maine hospitals have reported negative operating margins each year. This is not sustainable.

 

EMHS is doing what it can to keep local access to affordable, high-quality care by organizing doctors, hospitals and other providers into a coordinated system of care. By working together, we are able to more consistently follow clinical best practices, get better discounts on expensive medical equipment and supplies, avoid unnecessary and costly duplication of services, and invest in and benefit from a strong set of common support services. This leads to excellent care close-to-home, and to a seamless and coordinated transfer to other system facilities and resources when this is required.

We have also fully embraced what is known as “accountable care,” delivering better coordinated care to our patients. Providers work together to address quality, engagement and the overall cost of care while supporting Maine’s most vulnerable residents, many of whom are living with a chronic disease. This has helped reduce medication errors, unnecessary emergency department visits and has increased individual responsibility for adhering to tailored plans of care.

Along with improving the cost and quality of care to individuals, EMHS also looks out for the health of Maine’s communities. This is done through partnerships with community health and social service groups, and public health organizations across the state. A few examples of the community benefit in our 2016 fiscal year include:

EMHS provided $29.1 million in free or reduced price care to Mainers who qualify under our financial assistance policy.

EMHS hospitals partnered with our communities to improve health outside the walls of our facilities, investing $3.8 million in programs such as health education; community-based clinical services, such as blood pressure, cholesterol, bone density, glucose and other screenings; health care support services, such as Sebasticook’s courtesy van that provides free transportation from qualifying patient’s homes to the hospital or doctor’s appointments; and social and environmental improvement activities such as providing healthy food options by collaborating with community partners to address needs in our communities.

EMHS provided nearly $2.7 million in funding for clinical, community health and health care delivery research that can be shared with the public to improve health care.

EMHS invested $730,000 in community building activities that address the root causes of health problems such as homelessness and provided more than $435,000 in cash and in-kind contributions to community partnerships that advance the health of the communities we serve.

EMHS members were also instrumental in forging plans to combat the opioid abuse that is rampant in Maine. In the Portland, Bangor, Down East and Aroostook regions, EMHS hospitals and other members worked alongside police and sheriffs and other health care providers on this timely and concerning issue.

EMHS partnered with colleges and universities to provide training for jobs in health care for Maine’s younger generation, which also will help meet the state’s health care needs going forward, investing $2.6 million in such programs.

Health care is in a transformative time. Access to high-quality and affordable care is critical to the individuals and communities of our state. EMHS is an important community asset and partner. By coordinating health care as a system, EMHS is doing the right things toward not only preserving but improving high value health care.

http://www.nbcnews.com/news/us-news/maines-first-lady-ann-lepage-takes-summertime-waitressing-job-pick-n598906

Maine’s First Lady Ann LePage Takes Summertime Waitressing Job to Pick Up Cash

Maine is also is in the process to implement some the most strict opiate dosing guidelines. Since most chronic pain pts are struggling financially… and on Medicaid ?… if the state is in such financial trouble  – that the first lady has to take a summer job  – is the the reduced medical care to the chronic pain community just another means of “cost cutting”… using the fabricated “opiate epidemic” as the ruse to pass those opiate dosing guidelines  ?

Special Guest: Dr. Teitelbaum, MD May 24th 09:00 EDT

www.livesupportgroup.com/join-us/

CLICK LINK TO REGISTER FOR MEETING